COVID-19

Covid: Pfizer Crushes Competition with Vaccines and Antivirals

Posted on dec. 2021 at 7:25Updated December 22. 2021 at 7:35

A complete box. With its Covid vaccine now licensed for all adults in the United States and Europe, but also for children ages 5 and up, Pfizer is arguably the big winner from the pandemic. The US giant’s turnover is expected to reach $ 101.3 billion next year, including 29.7 billion from its Comirnaty anti-Covid vaccine, but also 24.2 from Paxlovid, the anti-Covid pill, according to the estimates from an analyst at SVB Leerink.

101 billion is double the 53 billion published by Pfizer in 2018, before selling its family drug business to GSK in 2019. And it is mostly a small revolution in the pharmaceutical industry, as the coronavirus could well allow the laboratory, well supported in the case of its German partner BioNTech, to overtake its great rival J&J and climb to the first step of the world podium in the sector.

WeaPlay, WordPress Theme, Business Consulting Nulled, Avada 7.4 Nulled, Newspaper – News & WooCommerce WordPress Theme, Nulledfire, Elementor Pro Weadown, Astra Pro Nulled, Plugins, Rank Math Seo Pro Weadown, Woodmart Theme Nulled, Elementor Pro Weadown,Woodmart Theme Nulled, Wordfence Premium Nulled, Flatsome Nulled, Yoast Nulled, Woocommerce Custom Product Ad, Jannah Nulled, Dokan Pro Nulled, Fs Poster Plugin Nulled, Jnews 8.1.0 Nulled, PW WooCommerce Gift Cards Pro Nulled, Newspaper 11.2, Premium Addons for Elementor, Slider Revolution Nulled, Wpml Nulled, PHP Script, WP Reset Pro, Consulting 6.1.4 Nulled

Back to top button